PATENT CLAIM ANALYSIS

Application Number: 16035274
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "185100"]

Abstract:
The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients. Specifically exemplified herein are endomorphin-1 peptide (EM-1), analogs and salts thereof, and uses for modulation of calcitonin gene-related peptide (CGRP) production and/or substance P (SP) and for treatment of inflammation, particularly neurogenic inflammation.

Claim (Index 2):
The method, according to  claim 1 , further comprising administering an anti-inflammatory agent selected from the group consisting of a steroidal compound, hydrocortisone, a non-steroidal anti-inflammatory compound, acetylsalicylic acid (aspirin), ibuprofen, acetaminophen, and indomethacin, wherein the anti-inflammatory agent is administered before, during, or after the administration of said peptide or salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.48936
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15511697', '12064923', '13908636', '13847275', '14727589']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.643641209620277
- 35 USC 102 Novelty (BERT): 0.5118400420274967
- Combined Prediction Score: 0.630461092860999
- Mean Citation Score: 217.598952
- Max Citation Score: 270.92593
- Similarity Product: 200.12149553208

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test